Li XJ - Search Results

1

Pharmacokinetics and bioavailability of cimicifugosides after oral administration of Cimicifuga foetida L. extract to rats.

Gai YY, Liu WH, Sha CJ, Wang YL, Sun YT, Li XJ, Paul Fawcett J, Gu JK. Gai YY, et al. Among authors: li xj. J Ethnopharmacol. 2012 Aug 30;143(1):249-55. doi: 10.1016/j.jep.2012.06.031. Epub 2012 Jul 3. J Ethnopharmacol. 2012. PMID: 22771280

2

Comparative pharmacokinetics and bioavailability of escin Ia and isoescin Ia after administration of escin and of pure escin Ia and isoescin Ia in rat.

Wu XJ, Zhang ML, Cui XY, Gao F, He Q, Li XJ, Zhang JW, Fawcett JP, Gu JK. Wu XJ, et al. Among authors: li xj. J Ethnopharmacol. 2012 Jan 6;139(1):201-6. doi: 10.1016/j.jep.2011.11.003. Epub 2011 Nov 10. J Ethnopharmacol. 2012. PMID: 22094055

3

Quantitation of bivalirudin, a novel anticoagulant peptide, in human plasma by LC-MS/MS: Method development, validation and application to pharmacokinetics.

Li XJ, Sun YT, Yin L, Zhang XJ, Yang Y, Paul Fawcett J, Cui YM, Gu JK. Li XJ, et al. J Pharm Anal. 2013 Feb;3(1):1-8. doi: 10.1016/j.jpha.2012.10.006. Epub 2012 Nov 7. J Pharm Anal. 2013. PMID: 29403790 Free PMC article.

4

Single-dose pharmacokinetic properties, bioavailability, and tolerability of two lamivudine 100-mg tablet formulations: a randomized crossover study in healthy Chinese male subjects.

Li X, Liu B, Sun Y, Chen H, Chen H, Zhang H, Zhang Q, Ding Y. Li X, et al. Clin Ther. 2013 Oct;35(10):1546-56. doi: 10.1016/j.clinthera.2013.07.431. Epub 2013 Sep 5. Clin Ther. 2013. PMID: 24011635 Clinical Trial.

5

Comparison of pharmacokinetics and safety between CE-fosphenytoin sodium, fosphenytoin sodium, and phenytoin sodium after intravenous and intramuscular administration in healthy volunteers.

Li X, Wu M, Sun J, Jin W, Han L, Xu J, Liu J, Zhang H, Wang J, Wang D, Zhang H, Zhang Q, Liu N, Ding Y. Li X, et al. Front Pharmacol. 2023 Nov 17;14:1204075. doi: 10.3389/fphar.2023.1204075. eCollection 2023. Front Pharmacol. 2023. PMID: 38044946 Free PMC article.

6

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of the Anti-IFNAR1 Monoclonal Antibody QX006N: A First-in-Human Single Ascending Dose Study in Healthy Chinese Volunteers.

Li X, Li B, Wang M, Fang M, Lou J, Liu J, Chen H, Ding Y. Li X, et al. BioDrugs. 2024 Mar;38(2):313-321. doi: 10.1007/s40259-023-00637-y. Epub 2023 Dec 27. BioDrugs. 2024. PMID: 38148466 Clinical Trial.

7

Safety, Pharmacokinetics, and Pharmacodynamics of a Dipeptidyl Peptidase-4 Inhibitor: A Randomized, Double-Blinded, Placebo-Controlled Daily Administration of Fotagliptin Benzoate for 14 Days for Type 2 Diabetes Mellitus.

Wu M, Li QQ, Zhang H, Zhu XX, Li XJ, Li Y, Sun HG, Ding YH. Wu M, et al. Among authors: li qq, li y, li xj. Clin Pharmacol Drug Dev. 2021 Jun;10(6):660-668. doi: 10.1002/cpdd.895. Epub 2021 Jan 13. Clin Pharmacol Drug Dev. 2021. PMID: 33440080 Clinical Trial.

8

Safety, pharmacokinetics, and efficacy of rifasutenizol, a novel dual-targeted antibacterial agent in healthy participants and patients in China with Helicobacter pylori infection: four randomised clinical trials.

Li X, Liu Y, Wang M, Gao L, Liu J, Zhang H, Wu M, Chen H, Lou J, Wang J, Chen J, Geng G, Ma Z, Ding Y. Li X, et al. Lancet Infect Dis. 2024 Jun;24(6):650-664. doi: 10.1016/S1473-3099(24)00003-3. Epub 2024 Feb 12. Lancet Infect Dis. 2024. PMID: 38359854 Clinical Trial.

9

A phase 1 randomized study compare the pharmacokinetics, safety and immunogenicity of HLX04 to reference bevacizumab sourced from the United States, the European Union, and China in healthy Chinese male volunteers.

Zhu X, Qian H, Sun J, Wu M, Yu C, Ding Y, Zhang X, Chai K, Li X. Zhu X, et al. Cancer Chemother Pharmacol. 2021 Sep;88(3):465-474. doi: 10.1007/s00280-021-04297-z. Epub 2021 Jun 4. Cancer Chemother Pharmacol. 2021. PMID: 34086067 Free PMC article. Clinical Trial.

10

Safety, Pharmacokinetics and Antiviral Efficacy of Capsid Assembly Modulator Freethiadine in Healthy Volunteers and Chronic Hepatitis B Patients.

Li X, Xu J, Sun J, Liu J, Wu M, Zhang H, Zhu X, Li C, Zhang Y, Zhu J, Chen Y, Luo L, He Q, Zhuang Y, Chen Y, Niu J, Ding Y. Li X, et al. Liver Int. 2025 Jan;45(1):e16213. doi: 10.1111/liv.16213. Liver Int. 2025. PMID: 39673713 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,371 results

Search Page

Filters